Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation
Authors:
- Francesco CicciaFCFrancesco Ciccia
- Michele BombardieriMBMichele Bombardieri
- Aroldo RizzoARAroldo Rizzo
- Alfonso PrincipatoAPAlfonso Principato
- Anna R. GiardinaAGAnna R. Giardina
- Francesca RaiataFRFrancesca Raiata
- Sergio PeraltaSPSergio Peralta
- Angelo FerranteAFAngelo Ferrante
- Sandro DragoSDSandro Drago
- Mario CottoneMCMario Cottone
- Costantino PitzalisCPCostantino Pitzalis
- Giovanni TrioloGTGiovanni Triolo
Open Access
- 5 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (11) , 2076-2083
Abstract
Objectives. Subclinical gut inflammation has been demonstrated in patients with AS. Altered expression of paneth cell (PC) anti-microbial peptides have been reported in the inflamed ileum of patients with Crohn’s disease (CD). Here, we investigated the expression of PC-derived peptides in subclinical gut inflammation in AS. Methods. Multiple adjacent mucosal biopsies from terminal ileum were obtained from 25 patients with AS, 30 CD and 15 healthy controls (HCs). Expression of human α-defensin 5 (HD-5), phospholipase A2 (PLA2), lysozyme and SOX-9 molecules was assessed by quantitative Taqman RT–PCR on mucosal samples. Immunohistochemistry with anti-human HD-5 antibody and genotyping of relevant NOD2 mutations was also performed. Results. HD-5, PLA2 and lysozyme transcript levels were strongly increased in AS and CD with similar degrees of intestinal inflammation when compared with normal controls. Immunohistochemical evaluation showed a normal number of PCs in both AS patients with chronic gut inflammation and CD patients with less-inflamed ileal samples. Conversely, CD patients with higher degree of gut inflammation had a reduced number of PCs and low expression levels of HD-5. Conclusion. In this study, we provide evidence that over-expression of PC-derived anti-microbial peptides occurs in the ileum of AS patients with subclinical gut inflammation, likely representing an important early alteration of the mucosal innate immune component and intestinal host defence in AS.Keywords
This publication has 30 references indexed in Scilit:
- Overexpression of interleukin‐23, but not interleukin‐17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitisArthritis & Rheumatism, 2009
- The Immune Response to Autologous Bacteroides in Ankylosing Spondylitis Is Characterized by Reduced Interleukin 10 ProductionThe Journal of Rheumatology, 2009
- Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s diseaseGut, 2008
- Paneth cell antimicrobial peptides: Topographical distribution and quantification in human gastrointestinal tissuesFEBS Letters, 2006
- Paneth cells: leukocyte-like mediators of innate immunity in the intestineJournal of Leukocyte Biology, 2006
- Reduced Paneth cell α-defensins in ileal Crohn's diseaseProceedings of the National Academy of Sciences, 2005
- NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expressionGut, 2004
- Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitisGut, 2003
- Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort studyThe Lancet, 2002
- Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathyAnnals of the Rheumatic Diseases, 2001